PRISM in the media

Hope found in magic mushrooms and MDMA

Psychedelic drugs could revolutionise current treatment options for mental health conditions as growing evidence demonstrates the profound effects of Psilocybin and MDMA. Over 100 studies in the US have examined

Read More »

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.

PRISM

We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.

Newsletter

Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search